Neoadjuvant Radiotherapy for Breast Cancer
Neoadjuvant Radiotherapy Versus Adjuvant Radiotherapy for Breast Cancer: A Phase II Exploratory Randomized Controlled Clinical Study
Changhai Hospital
60 participants
Apr 1, 2024
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to compare the effects of neoadjuvant radiotherapy and adjuvant radiotherapy in patients with breast cancer. The main questions it aims to answer are: * The clinical effect of neoadjuvant radiotherapy for breast cancer was determined according to the postoperative specimens. * Evaluate the acute and late toxicity of preoperative radiotherapy Participants will be randomly divided into two groups: the neoadjuvant radiotherapy group and the adjuvant radiotherapy group.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The patient received synchronous radiotherapy and chemotherapy before surgery. CTV : 40Gy/15fx/3w, sequential GTV: 8.7-10Gy/3-4 Fx.CTV : 40Gy/15fx/3w, sequential GTV: 8.7-10Gy/3-4 Fx.
The patient received radiotherapy after surgery. CTV : 40Gy/15fx/3w, sequential GTV: 8.7-10Gy/3-4 Fx.CTV : 40Gy/15fx/3w, sequential GTV: 8.7-10Gy/3-4 Fx.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06313073